Featured Research

from universities, journals, and other organizations

Scientists uncover evidence on how drug-resistant tuberculosis cells form

Date:
December 19, 2011
Source:
Harvard School of Public Health
Summary:
A new study provides a novel explanation as to why some tuberculosis cells are inherently more difficult to treat with antibiotics.

Mycobacterium smegmatis cell walls were stained with a green fluorescent dye. Following staining, the cells were grown in stain-free media, and new growth is unlabeled (appearing blue) while the old cell wall retains the green dye. Pictured here are two cells that have grown asymmetrically, each with a green pole (non-growing and made up of old, stained cell wall) and a blue pole (growing and made up of new cell wall).
Credit: Image courtesy of Harvard School of Public Health

A new study led by Harvard School of Public (HSPH) researchers provides a novel explanation as to why some tuberculosis cells are inherently more difficult to treat with antibiotics. The discovery, which showed that the ways mycobacteria cells divide and grow determine their susceptibility to treatment with drugs, could lead to new avenues of drug development that better target tuberculosis cells.

The study appears December 15, 2011 in an advance online edition of Science.

"We have found that the consequences of the simple and unexpected patterning of mycobacterial growth and division means some bacterial cells have the capacity to survive in the face of antibiotics," said Bree Aldridge, a postdoctoral fellow at HSPH and co-first author of the study.

Tuberculosis is an infectious disease that kills more than 1.5 million people annually. It is a difficult disease to treat; people are prescribed a combination of antibiotics to be taken daily for six to nine months, a regimen that is hard for patients to follow and for nurses and doctors to administer. Even after beginning appropriate treatment, it appears that some of the infectious cells survive for long periods of time.

The HSPH researchers, led by Aldridge, co-first author and visiting scientist Marta Fernandez-Suarez, and senior author Sarah Fortune, assistant professor of immunology and infectious diseases, along with colleagues from Massachusetts General Hospital, set out to determine what distinguishes a cell that lives from one that dies. They designed a unique microfluidic chamber in which they grew Mycobacterium smegmatis cells (which behave similarly to Mycobacterium tuberculosis cells) and filmed their growth with a live-cell imaging system.

Mycobacterium smegmatis cell walls were stained with a green fluorescent dye. Following staining, the cells were grown in stain-free media, and new growth is unlabeled (appearing blue) while the old cell wall retains the green dye. Pictured here are two cells that have grown asymmetrically, each with a green pole (non-growing and made up of old, stained cell wall) and a blue pole (growing and made up of new cell wall).

The researchers thought that the M. smegmatis cells would divide evenly into similar-sized daughter cells, as bacteria such as E. coli do. Instead, they were surprised to find that the M. smegmatis daughter cells were incredibly diverse, with highly variable sizes and growth rates. They found that this diversity arises because M. smegmatis grow in an unusual fashion, elongating from only one end. When an asymmetric mother cell divides, it creates daughter cells that are very different from one another in fundamental ways, including their growth properties.

The researchers speculated that these physiologically distinct subpopulations of cells would translate into differences in their susceptibility to antibiotics, which target processes essential for growth and division. To test this hypothesis, they treated the cells with different classes of antibiotics and observed how subpopulations of daughter cells responded.

The results showed that the different daughter cells exhibited varying susceptibilities to the treatments, strong evidence that populations of mycobacterial cells contain cells that are inherently tolerant of antibiotics and providing an important piece to the puzzle of why tuberculosis is such a difficult disease to treat.

"It is surprising to discover that mycobacteria differ from other bacteria such as E. coli in such a fundamental way," said Fortune. "It is easy to assume that most bacteria work in a similar fashion. While that's true sometimes, this study shows that bacterial species, such as TB, may be strikingly different from each other and thus require different methods of treatment." The researchers hope that their findings lead to the development of treatment regimens in which antibiotics are combined to specifically target tolerant subpopulations of cells.

Support for this study was provided by a National Institute of Health Director's New Innovator Award, Doris Duke Charitable Foundation, the United States Army Medical Research Acquisition Activity, the National Institute of Biomedical Imaging and Bioengineering and the Massachusetts General Hospital Executive Committee on Research.

"Asymmetry and aging of mycobacterial cells leads to variable growth and antibiotic susceptibility," Science, Bree B. Aldridge, Marta Fernandez-Suarez, Danielle Heller, Vijay Ambravaneswaran, Daniel Irimia, Mehmet Toner, Sarah Fortune, online Dec. 15, 2011


Story Source:

The above story is based on materials provided by Harvard School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. B. B. Aldridge, M. Fernandez-Suarez, D. Heller, V. Ambravaneswaran, D. Irimia, M. Toner, S. M. Fortune. Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility. Science, 2011; DOI: 10.1126/science.1216166

Cite This Page:

Harvard School of Public Health. "Scientists uncover evidence on how drug-resistant tuberculosis cells form." ScienceDaily. ScienceDaily, 19 December 2011. <www.sciencedaily.com/releases/2011/12/111215141619.htm>.
Harvard School of Public Health. (2011, December 19). Scientists uncover evidence on how drug-resistant tuberculosis cells form. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2011/12/111215141619.htm
Harvard School of Public Health. "Scientists uncover evidence on how drug-resistant tuberculosis cells form." ScienceDaily. www.sciencedaily.com/releases/2011/12/111215141619.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins